Oncology trials represent 20% of our business. Cortex has proven expertise in conducting trials in the field of NSCLC, prostate cancer, glioblastoma, colon cancer, oral mucositis in colon cancer patients, breast cancer, chemotherapy induced anaemia, ovarium cancer, testicular cancer, cervix cancer and liver cancer. We’ve established broad network with the Hungarian oncologists who prove outstanding interest in newly developed anti-cancer medications.

Our site became top recruiter in an academic study conducted in 6 countries at 38 sites in breast cancer indication.

Diabetes and metabolic disorders are amongst the most frequent diseases of the developed countries. Our Hungarian client is developing a nutritional supplement treating type II diabetes.

Our top recruiter site of a study conducted in patients with Sytemic Lupus Erythematosus was audited by the sponsor with excellent result and emphasizing the CRA’s role.

Cortex performed the monitoring of the phase II and phase III development of a new contraception system. Our investigator recruited 88 healthy volunteers becoming the 2nd biggest recruiter in this worldwide project.

We also managed the start-up activities of a trial planned to be conducted in patients suffering from endometriosis and prepared clinical investigational protocol of trials in the indication of bacterial vaginosis and infertility.

We are participating in new projects of different clients investigating the effect of new medical devices developed for the prevention / therapy of gynaecological diseases.